Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Total Current Liabilities (2020 - 2023)

Historic Total Current Liabilities for Terns Pharmaceuticals (TERN) over the last 4 years, with Q3 2023 value amounting to $12.1 million.

  • Terns Pharmaceuticals' Total Current Liabilities rose 6156.93% to $12.1 million in Q3 2023 from the same period last year, while for Sep 2023 it was $12.1 million, marking a year-over-year increase of 6156.93%. This contributed to the annual value of $8.5 million for FY2022, which is 2416.42% up from last year.
  • According to the latest figures from Q3 2023, Terns Pharmaceuticals' Total Current Liabilities is $12.1 million, which was up 6156.93% from $14.2 million recorded in Q2 2023.
  • Over the past 5 years, Terns Pharmaceuticals' Total Current Liabilities peaked at $22.8 million during Q4 2020, and registered a low of $5.8 million during Q2 2021.
  • In the last 4 years, Terns Pharmaceuticals' Total Current Liabilities had a median value of $7.9 million in 2021 and averaged $9.8 million.
  • Its Total Current Liabilities has fluctuated over the past 5 years, first tumbled by 7011.52% in 2021, then skyrocketed by 13557.25% in 2023.
  • Terns Pharmaceuticals' Total Current Liabilities (Quarter) stood at $22.8 million in 2020, then crashed by 70.12% to $6.8 million in 2021, then grew by 24.16% to $8.5 million in 2022, then soared by 42.74% to $12.1 million in 2023.
  • Its Total Current Liabilities stands at $12.1 million for Q3 2023, versus $14.2 million for Q2 2023 and $12.1 million for Q1 2023.